Symbol: |
SPG21
|
Description: |
spastic paraplegia 21 (autosomal recessive, Mast syndrome) [Source:HGNC Symbol;Acc:20373]
|
Location: |
Chr15:65255362-65282648[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:191
Gene |
Compound |
Gen_sig |
Exp_pattern |
SPG21 |
2-Imidazoline-1-ethanol, .alpha.,4,4-trimethyl-2-undecyl- |
0.014 |
Down |
SPG21 |
NSC 205628 |
0.018 |
Up |
SPG21 |
1H-Pyrazole-5-carboxylic acid, 4,5-dihydro-1,3-diphenyl-, potassium salt |
0.032 |
Down |
SPG21 |
Buclizine Hydrochloride |
0.001 |
Down |
SPG21 |
NSC 26669 |
0.001 |
Down |
SPG21 |
NSC 27413 |
0.002 |
Down |
SPG21 |
1H-Benz[g]indazole-3-carboxamide,1-(4-chlorophenyl)- N-[2-(diethylamino)ethyl]-4,5-dihydro-7-methoxy-, monohydrochloride |
0.011 |
Down |
SPG21 |
NSC 303769 |
0.01 |
Down |
SPG21 |
7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine, 7-[(4-aminophenyl)methyl]-, dihydrochloride |
0.015 |
Down |
SPG21 |
3',4',5'-Trimethoxyflavone |
0.015 |
Up |
SPG21 |
5,5'-bis(2-methyl-1H-indol-3-yl)-3,3'-biisoxazole |
0.043 |
Down |
SPG21 |
ANTINEOPLASTIC-376265 |
0.042 |
Down |
SPG21 |
NSC 41274 |
0.001 |
Down |
SPG21 |
NSC 53454 |
0.044 |
Down |
SPG21 |
NSC 604979 |
0.015 |
Down |
Expression pattern: Sensitivity / Resistance
Total:13 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:11
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:63
Total:5 Current:1
[First] [Prev]  Next Last 
|